Companion Diagnostics or Theransotics Products in the Market

http://www.sciclips.com/sciclips/blogArticle.do?id=1019&blog=Compa...

Home

About SciClips

Contact Us

Register

Login

Upload Videos

Open Innovation Platform for Scientific Breakthroughs, Collaborations and Philanthropism

Stem Cell Research | Proteomics / Biomarkers / Metabolomics | Drug Discovery | Biofuels | Tuberculosis | Mosquito-Borne Diseases

Companion Diagnostics or Theransotics Products in the Market

Tue, February 14 2012, 12:00 AM Posted By: Sciclips

Visit our section on

Most Cited Reagents

Visit our section on

Following are some of the companion diagnostics or theranostics products that are currently available (may not be available worldwide), in addition to the US FDA approved Genetech's Hercept with DakoCytomation's HercepTest for breast cancer and Roche's Zelboraf and companion diagnostic test for late-stage skin cancer. 1. DNA tests for Heart medication | Clopidogrel Genetic Test (from Theranostics Lab). 2. DNA tests for Heart medication | Statin Genetic Test (from Theranostics Lab). 3. DNA tests for Heart medication | Warfarin Genetic Test (from Theranostics Lab). 4. AtheroAbzymeTM ELISA (from Cambridge Theranostics) - this test is used for identifying the risk of developing diseases caused by the oxidation of lipids due to the presence of active ALOA (Atherogenic Lipid-Oxidising Antibodies). This test can also be used for monitoring patients who were treated with anti-ALOA. 5. CancerTYPE ID (from bioTheranostics) - a molecular diagnostic test for the determination of tumor site of origin using differential expression of 92 genes. 6. Breast Cancer IndexSM- (from bioTheranostics) - a prognostic biomarker based test for the quantitative assessment of the likelihood of distant recurrence in estrogen receptor-positive, lymph node-negative breast cancer patients. 7. PRCISSM Precision Medicine (from bioTheranostics) - biomarker profiling based test for the detection of clinically relevant tumor biomarkers for non-small cell lung cancer (NSCLC) and colorectal cancer. 8. Therapy Selection Assay for Ductal Carcinoma in Situ (Breast Cancer) (from Target Discovery). 9. Tumor Aggressiveness Assay for Prostate Cancer (from Target Discovery). 10. Chemotherapy Selection in Ovarian Cancer (from TargetDiscovery). 11. CVDefine kit: ELISA based immunoassay kit for the early detection of lesions in the artery wall caused by inflammation (from Athera Biotechnologies AB). 12. Aetiological diagnosis of AKI (from Bio-inRen)- urinary marker based test for monitoring hypertension and antihypertensive therapy efficacy. 13. Acquired risk of kidney injury (from Bio-inRen)- biomarkers based test to detect patients with increased risk of developing acute kidney injury from a drug treatment. 14. InformMDx (from MDxHealth) - prognostic assay for differentiating aggressive and non-aggressive tumors (prostate and lung cancer) (product pipeline). 15. PredictMDx (from MDxHealth) - a predictive test to identify which drug or treatment regimen is likely to be most effective for prostate and lung cancer patients (product pipeline). Related blogs: 1. Cancer Theranostics - Potential Applications of Cancer Biomarker Database Related tools: 5. Comprehensive cancer biomarker database with companion diagnostics pathway

Bioprotocols

www.twitter.com/sciclips

All Open Innovation Legal and Ethics Stem Cells Proteomics Drug Discovery

On Wed, January 25 2012, 04:17 PM Sciclips commented on Cancer Theranostics Potential Applications of Cancer Biomarker Database "Please join the following

discussion group:
LinkedIn Theranostics group " On Tue, January 24 2012, 07:10 PM Sciclips commented on Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities

"Additional comments on this topic can be seen at Linkedin Nuclear Receptor Resource group (open group):
On Thu, January 19 2012, 04:22 AM Harish commented on Cancer Theranostics Potential Applications of Cancer Biomarker Database "Nice article, very usefull" On Tue, January 17 2012, 07:27 PM Sciclips commented on Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities "We are

trying to identify and create a list of technologies or products related to drug discovery/development assays, which do not involve genetic manipulation of cells or reporter genes/proteins or m..."

1 of 3

2/14/2012 11:20 PM

Companion Diagnostics or Theransotics Products in the Market

http://www.sciclips.com/sciclips/blogArticle.do?id=1019&blog=Compa...

On Tue, January 17 2012, 07:54 AM rnc123 commented on Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities "It is also

interesting to point out that transfection reagents used in creating cell based reporters can also have an impact genetic and protein functions in cells. Citations: 1. Transcriptional eff..."
Categories: Biomarkers

On Tue, November 08 2011, 04:30 PM Dutch commented on "Idea stealing"- does it affect scientific innovation and creativity? "I'll

Post a comment

second T Johnson as I am basically trying to make the same point. Most of the ideas "stolen" are application based and not truly original ideas. Very few people ever have true, revolutionary co..."
On Tue, September 27 2011, 11:30 PM DMPK commented on "Idea stealing"- does it affect scientific innovation and creativity?

Choose an identity Sciclips Account User name: Password : Anonymous

"Stealing ideas is ofcourse the best example of bankruptcy of the boss, it is because no attention is paid about the suitability of the person for the position due to favoritism. The boss can be duffe..."
On Tue, September 20 2011, 07:33 AM Sciclips commented on "Idea stealing"- does it affect scientific innovation and creativity?

Enter challenge text as seen on the right: Post Your Comment

"Please see a very interesting comment on this blog topic in Cafepharma discussion forum: http://www.cafepharma.com/boards /showthread.php?p=4066217"
On Fri, August 26 2011, 10:09 AM Sciclips commented on Cell based reporter assays: misleading approach in drug discovery? "See

the comments in Wordpress: http://sciclips.wordpress.com /2010/10/25/cell-based-reporterassays-misleading-approach-in-drugdiscovery/"

On Fri, August 26 2011, 10:07 AM Sciclips commented on Are large protein fusion tag based technologies, including protein arrays, truly useful in functional proteomics or systems biology or drug discovery research?

"See the comments in Wordpress: http://tinyurl.com/29oqhpc"

Companion Diagnostics or Theransotics Products in the Market

Posted on Tue, February 14 2012, 12:00 AM

Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities
Posted on Sun, January 15 2012, 12:00 AM

Cancer Theranostics - Potential Applications of Cancer Biomarker Database Posted on Sun, January 08 2012,
12:00 AM

"Idea stealing"- does it affect scientific innovation and creativity?

Posted on Thu, August 18 2011, 12:00 AM

2 of 3

2/14/2012 11:20 PM

Companion Diagnostics or Theransotics Products in the Market

http://www.sciclips.com/sciclips/blogArticle.do?id=1019&blog=Compa...

Is it too early to brand biomarker discovery as a "Hype"? Posted on Mon,

August 01 2011, 12:00 AM

Are stem cells ready as a next generation drug discovery tool? Posted
on Mon, December 20 2010, 12:00 AM

Cell based reporter assays: misleading approach in drug discovery? Posted on Mon, October 25
2010, 12:00 AM

Are large protein fusion tag based technologies, including protein arrays, truly useful in functional proteomics or systems biology or drug discovery research? Posted on Tue,
October 05 2010, 12:00 AM

Stem Cell Research Reagents: Future Perspectives Posted on Sun, June 20 2010,
12:00 AM

Are current cell-based assays truly reliable for drug screening? Posted on
Sun, December 06 2009, 12:00 AM

SciClips LLC, 1202 Ann Street, Madison, WI 53713 USA; contact@sciclips.com All Rights Reserved 2009-2012

3 of 3

2/14/2012 11:20 PM